BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$725M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$694M |
| 3 |
Microsoft
MSFT
|
+$320M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$216M |
| 5 |
Amazon
AMZN
|
+$211M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$153M |
| 2 |
Bank of America
BAC
|
+$130M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$62.1M |
| 4 |
STJ
St Jude Medical
STJ
|
+$55.6M |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$50.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.95% |
| 2 | Financials | 11.02% |
| 3 | Healthcare | 9.12% |
| 4 | Communication Services | 8.65% |
| 5 | Consumer Discretionary | 7.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KEM
3076
DELISTED
KEMET Corporation
KEM
| $13.3K | ﹤0.01% |
+1,110
| New | +$10.1K |
|
|
PRMW
3077
DELISTED
Primo Water Corporation
PRMW
| $13.3K | ﹤0.01% |
977
-150
| -13% | -$2.06K |
|
3078
Waterstone Financial
WSBF
$378M
| $13.2K | ﹤0.01% |
722
-943
| -57% | -$17.2K |
|
3079
Babcock & Wilcox
BW
$1.46B
| $13.1K | ﹤0.01% |
140
-120
| -46% | -$16.8K |
|
3080
SiriusPoint
SPNT
$2.66B
| $13K | ﹤0.01% |
1,078
-3,827
| -78% | -$45.3K |
|
3081
Lexicon Pharmaceuticals
LXRX
$1.05B
| $13K | ﹤0.01% |
909
-464
| -34% | -$6.88K |
|
|
QUOT
3082
DELISTED
Quotient Technology Inc
QUOT
| $13K | ﹤0.01% |
1,358
-3,257
| -71% | -$36K |
|
3083
QuidelOrtho
QDEL
$1.02B
| $12.9K | ﹤0.01% |
572
-297
| -34% | -$6.14K |
|
|
ACRE
3084
Ares Commercial Real Estate
ACRE
$261M
| $12.9K | ﹤0.01% |
964
-889
| -48% | -$12K |
|
|
ARNA
3085
CALL
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $12.9K | ﹤0.01% |
75
+25
| +50% | +$370 |
|
|
FOLD
3086
DELISTED
Amicus Therapeutics
FOLD
| $12.9K | ﹤0.01% |
1,803
-1,816
| -50% | -$11.5K |
|
3087
Karyopharm Therapeutics
KPTI
$46M
| $12.8K | ﹤0.01% |
66
-24
| -27% | -$3.85K |
|
3088
CALL
Constellation Brands
STZ
$22.9B
| $12.7K | ﹤0.01% |
20
-95
| -83% | -$14.8K |
|
3089
First Merchants
FRME
$2.72B
| $12.7K | ﹤0.01% |
322
-3,017
| -90% | -$118K |
|
3090
Kadant
KAI
$3.94B
| $12.6K | ﹤0.01% |
213
-707
| -77% | -$42.9K |
|
|
AVID
3091
DELISTED
Avid Technology Inc
AVID
| $12.6K | ﹤0.01% |
2,706
-345
| -11% | -$1.78K |
|
|
RAI
3092
PUT
DELISTED
Reynolds American Inc
RAI
| $12.5K | ﹤0.01% |
1,661
-2,574
| -61% | -$155K |
|
3093
Globalstar
GSAT
$10.8B
| $12.5K | ﹤0.01% |
521
-478
| -48% | -$10.7K |
|
3094
CALL
Terex
TEX
$7.8B
| $12.5K | ﹤0.01% |
+151
| New | +$4.74K |
|
|
MCRN
3095
DELISTED
Milacron Holdings Corp.
MCRN
| $12.4K | ﹤0.01% |
665
-574
| -46% | -$10.4K |
|
|
ITCI
3096
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $12.3K | ﹤0.01% |
756
-340
| -31% | -$4.92K |
|
|
CWEN.A
3097
DELISTED
Clearway Energy Class A
CWEN.A
| $12K | ﹤0.01% |
692
-1,504
| -68% | -$24.7K |
|
|
REN
3098
DELISTED
Resolute Energy Corporaton
REN
| $11.9K | ﹤0.01% |
295
-23,979
| -99% | -$1.03M |
|
3099
Valvoline
VVV
$4.25B
| $11.8K | ﹤0.01% |
480
| – | – |
|
3100
Evolent Health
EVH
$471M
| $11.6K | ﹤0.01% |
519
-203
| -28% | -$3.9K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2017 Portfolio in Review
As of Q1 2017, BNP Paribas Financial Markets held 4,403 positions worth $37.9B, up 77% from $21.3B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BNP Paribas Financial Markets deployed $14.9B of net new capital in Q1 2017, opening 244 new positions and adding to 1,412 existing holdings. Its largest new stake was State Street SPDR S&P Metals & Mining ETF: 1,526,590 shares worth $46.4M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 9.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares US Real Estate ETF, an estimated $153M trimmed.
- BNP Paribas Financial Markets's largest Q1 2017 buy was State Street SPDR S&P Metals & Mining ETF: 1,526,590 shares worth $46.4M.
- BNP Paribas Financial Markets added most to Apple in Q1 2017, an estimated $725M increase.
- BNP Paribas Financial Markets's biggest Q1 2017 reduction was iShares US Real Estate ETF, cutting an estimated $153M.
- BNP Paribas Financial Markets fully exited St Jude Medical in Q1 2017, selling an estimated $55.6M.
- BNP Paribas Financial Markets's ten largest holdings make up 19% of its $37.9B portfolio in Q1 2017.
- BNP Paribas Financial Markets opened 244 new positions and closed 335 in Q1 2017.
- BNP Paribas Financial Markets's portfolio value rose 77% quarter-over-quarter to $37.9B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2017, filed 3 May 2017.